Dose-ranging studies of anisoylated plasminogen streptokinase activator complex. Studies in healthy volunteers and in patients with acute myocardial infarction.
Drugs., 33 Suppl 3:124-32 (1987)
Cardiac output by rebreathing in patients with cardiopulmonary diseases.
J. Appl. Physiol., Jul;63(1):201-10 (1987)
Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: controlled comparison with intracoronary streptokinase.
J. Am. Coll. Cardiol., Jun;11(6):1153-63 (1988)
Dependence of assessment of coronary artery reperfusion during acute myocardial infarction on angiographic criteria and interobserver variability.
Am. J. Cardiol., Sep;62(9):538-42 (1988)
Effect of reperfusion on electrocardiographic and enzymatic infarct size: results of a randomized multicenter study of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) versus intracoronary streptokinase in acute myocardial infar
Am. Heart J., Oct;116(4):903-14 (1988)
Relation of plasma D-dimer concentrations to coronary artery reperfusion before and after thrombolytic treatment in patients with acute myocardial infarction.
Am. J. Cardiol., May;63(17):1179-84 (1989)
Rapid lysis of coronary artery thrombi with anisoylated plasminogen: streptokinase activator complex. Treatment by bolus intravenous injection.
Ann. Intern. Med., Mar;104(3):304-10 (1986)
Hemodynamic and respiratory effects of dezocine, ciramadol, and morphine.
Clin. Pharmacol. Ther., Jul;38(1):84-8 (1985)
Clinical evaluation of a radiometric assay specific for creatine kinase isoenzyme MB.
Clin. Chem., Jun;27(6):828-31 (1981)
Relationship of the lytic state to successful reperfusion with standard- and low-dose intracoronary streptokinase.
Circulation., Mar;71(3):562-70 (1985)